Literature DB >> 11973239

Gene therapy: new "magic bullets" to prevent ocular scarring.

P T Khaw, A D Cambrey, G A Limb, J T Daniels.   

Abstract

Mesh：

Year:  2002        PMID： 11973239      PMCID： PMC1771119          DOI： 10.1136/bjo.86.5.490

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  12 in total

1.  Peripheral infection with adenovirus causes unexpected long-term brain inflammation in animals injected intracranially with first-generation, but not with high-capacity, adenovirus vectors: toward realistic long-term neurological gene therapy for chronic diseases.

Authors:  C E Thomas; G Schiedner; S Kochanek; M G Castro; P R Löwenstein
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

Review 2.  Lentiviral vectors: turning a deadly foe into a therapeutic agent.

Authors:  D Trono
Journal:  Gene Ther       Date:  2000-01       Impact factor: 5.250

3.  The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators.

Authors: 
Journal:  Am J Ophthalmol       Date:  2000-10       Impact factor: 5.258

4.  Five-minute treatments with fluorouracil, floxuridine, and mitomycin have long-term effects on human Tenon's capsule fibroblasts.

Authors:  P T Khaw; M B Sherwood; S L MacKay; M J Rossi; G Schultz
Journal:  Arch Ophthalmol       Date:  1992-08

Review 5.  Human gene therapy.

Authors:  W F Anderson
Journal:  Nature       Date:  1998-04-30       Impact factor: 49.962

6.  Adenoviral-mediated gene transfer to the filtering bleb in rabbits.

Authors:  M Skaf; D S di Martino; P A de Arruda Mello; R Varma
Journal:  J Glaucoma       Date:  2001-12       Impact factor: 2.503

Review 7.  Activation and suppression of fibroblast function.

Authors:  P T Khaw; N L Occleston; G Schultz; I Grierson; M B Sherwood; G Larkin
Journal:  Eye (Lond)       Date:  1994       Impact factor: 3.775

8.  Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy : Results from a randomized, double-blind, controlled clinical trial.

Authors:  R H Asaria; C H Kon; C Bunce; D G Charteris; D Wong; P T Khaw; G W Aylward
Journal:  Ophthalmology       Date:  2001-07       Impact factor: 12.079

9.  Human anti-transforming growth factor-beta2 antibody: a new glaucoma anti-scarring agent.

Authors:  M F Cordeiro; J A Gay; P T Khaw
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-09       Impact factor: 4.799

10.  Human antitransforming growth factor beta(2) monoclonal antibody--a new modulator of wound healing in trabeculectomy: a randomized placebo controlled clinical study.

Authors:  Dilani Siriwardena; Peng T Khaw; Anthony J King; Mark L Donaldson; Barry M Overton; Clive Migdal; M Francesca Cordeiro
Journal:  Ophthalmology       Date:  2002-03       Impact factor: 12.079
View more
  1 in total

1.  [Macular hole surgery with air tamponade. Does air suffice for short-term tamponade?].

Authors:  C Gesser; T Eckert; U Eckardt; U Porkert; C Eckardt
Journal:  Ophthalmologe       Date:  2010-11       Impact factor: 1.059
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.